Skip to main content
Clinical Trials/NCT03735654
NCT03735654
Unknown
Not Applicable

Assessing the Impact of Muscle Strength and Fatigability on Gait Performance Using Single Joint and Multi-joint Assessments in People With Multiple Sclerosis

Washington D.C. Veterans Affairs Medical Center1 site in 1 country35 target enrollmentNovember 15, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Washington D.C. Veterans Affairs Medical Center
Enrollment
35
Locations
1
Primary Endpoint
Functional Ambulation Performance (FAP)
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to compare walking to leg strength and endurance in people with multiple sclerosis (PwMS). Using these findings, we hope to be better understand what causes PwMS to have problems walking.

Detailed Description

The purposes of the research are to determine the association of gait performance with lower extremity muscle fatigability and strength measures, and create a preliminary model that can better explain the variance in gait performance based on these muscle performance values. Objective criterion-based measures of physical fatigue (i.e., fatigability) and muscle weakness have been associated with impaired task performance in people with multiple sclerosis (MS). MS-related deficits in muscle capacity result in higher fall risks and a loss of function. However, it is unclear if lower extremity fatigability tests add clinical value to objective strength testing in the rehabilitation and clinical management of MS. Better understanding how patterns of lower extremity (LE) fatigability and strength affect mobility in people with MS could improve outcome measure development and inform rehabilitation strategies.

Registry
clinicaltrials.gov
Start Date
November 15, 2018
End Date
October 1, 2021
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Washington D.C. Veterans Affairs Medical Center
Responsible Party
Principal Investigator
Principal Investigator

Michael Harris-Love

Director, 3MAP Lab, and Assoc. Director, CRC Human Performance Research Unit

Washington D.C. Veterans Affairs Medical Center

Eligibility Criteria

Inclusion Criteria

  • Age 18-85 years
  • History of multiple sclerosis
  • Expanded Disability Status Scale \< 7.0
  • Receives care at the Washington DC Veteran's Affairs Medical Center Neurology Service and Multiple Sclerosis Center of Excellence - East

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Functional Ambulation Performance (FAP)

Time Frame: 1 Day

The FAP is used to quantify self-selected gait.

Hip, knee, and ankle fatigability

Time Frame: 1 Day

For isometric tests, a exhaustion time will be calculated by determining the time that peak impulse declines to 50% using a method validated for individual with MS.

Hip, knee, and ankle maximal volitional contraction

Time Frame: 1 Day

Maximal volitional contraction will be measured by the load cell using isometric expressed as peak torque.

Secondary Outcomes

  • Adult Myopathy Assessment Tool (AMAT)(1 Day)
  • 5 times sit to stand test (5STS)(1 Day)

Study Sites (1)

Loading locations...

Similar Trials